TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Deferred Tax Assets, Valuation Allowance USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Teva Pharmaceutical Industries Ltd quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2019 to 2023.
  • Teva Pharmaceutical Industries Ltd Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $3.01 B, a 2.05% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $3.01 B -$63 M -2.05% Dec 31, 2023 10-K 2024-02-12
Q4 2022 $3.07 B +$349 M +12.8% Dec 31, 2022 10-K 2024-02-12
Q4 2021 $2.72 B +$176 M +6.91% Dec 31, 2021 10-K 2023-02-10
Q4 2020 $2.55 B +$573 M +29% Dec 31, 2020 10-K 2022-02-09
Q4 2019 $1.97 B Dec 31, 2019 10-K 2021-02-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.